Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep;23(Suppl 3):S221-S225.
doi: 10.5005/jp-journals-10071-23257.

Reversal of Anticoagulants in Critical Care

Affiliations

Reversal of Anticoagulants in Critical Care

Binila Chacko et al. Indian J Crit Care Med. 2019 Sep.

Abstract

There has seen an increase in anticoagulant consumption worldwide over the past few decades. With this widespread utilization of anticoagulants, clinicians are increasingly likely to encounter situations where anticoagulants would need to be withheld. This includes emergency and elective procedures or surgeries as well as major or minor bleeding as a direct result of over anticoagulation or consequent to other intercurrent illnesses such as sepsis or trauma with multiorgan failure, where the anticoagulant may contribute to coagulation abnormalities. Clinicians are required to have a thorough understanding of the indications for anticoagulant prescription, drug interactions and monitoring, indications and options of reversal of anticoagulation and management of bleeding in the situations described above. Once the acute process is managed, the ongoing need and timing of reinitiation of anticoagulation is also crucial. This article provides an overview on the indications for reversal of anticoagulation, the agents used for reversal and the timing of reinitiation of anticoagulants.

How to cite this article: Chacko B, Peter JV, Subramani K. Reversal of Anticoagulants in Critical Care. Indian J Crit Care Med 2019;23(Suppl 3):S221-S225.

Keywords: Anticoagulant; Critical care; Direct thrombin inhibitors; Protamine; Reversal; Vitamin K antagonists.

PubMed Disclaimer

Conflict of interest statement

Source of support: Nil Conflict of interest: None

References

    1. Barnes GD,, Lucas E,, Alexander GC,, Goldberger ZD. National Trends in Ambulatory Oral Anticoagulant Use. The American Journal of Medicine. 2015 Dec;;128((12):):1300-–1302.. - PMC - PubMed
    1. Wendelboe AM,, Raskob GE. Circ Res. (9): Vol. 118. Lippincott Williams & Wilkins; Hagerstown, MD;: 2016 Apr 29;. Global Burden of Thrombosis: Epidemiologic Aspects. pp. 1340-–1347.. - PubMed
    1. Ustrell X,, Pellisé A. Cardiac workup of ischemic stroke. Curr Cardiol Rev. 2010 Sep 17;;6((3):):175-–183.. - PMC - PubMed
    1. Milling TJ,, Frontera J. Exploring indications for the Use of direct oral anticoagulants and the associated risks of major bleeding. Am J Manag Care. 2017 Apr 1;;23((4):):S67-–S80.. - PMC - PubMed
    1. Chai-Adisaksopha C,, Crowther M,, Isayama T,, Lim W. The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis. Blood. 2014 Oct 9;;124((15):):2450-–2458.. - PubMed

LinkOut - more resources